These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2566500)

  • 1. Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity.
    Morelli M; Fenu S; Garau L; Di Chiara G
    Eur J Pharmacol; 1989 Mar; 162(2):329-35. PubMed ID: 2566500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning.
    Morelli M; Di Chiara G
    Eur J Pharmacol; 1987 Sep; 141(1):101-7. PubMed ID: 3117576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors.
    Morelli M; Fenu S; Di Chiara G
    Life Sci; 1987 Jan; 40(3):245-51. PubMed ID: 2948094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1 and D2 dopamine receptor mechanisms in dopaminergic behaviors.
    Koller WC; Herbster G
    Clin Neuropharmacol; 1988 Jun; 11(3):221-31. PubMed ID: 3261198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement by the D1 dopamine agonist SKF 38393 of specific components of stereotypy elicited by the D2 agonists LY 171555 and RU 24213.
    Meller E; Bordi F; Bohmaker K
    Life Sci; 1988; 42(25):2561-7. PubMed ID: 3260320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of MK 801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen.
    Morelli M; Fenu S; Carta A; Di Chiara G
    Behav Brain Res; 1996 Sep; 79(1-2):93-100. PubMed ID: 8883820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SKF 38393 potentiates yawning induced by LY 171555: further evidence against the autoreceptor hypothesis of yawning.
    Spina L; Longoni R; Mulas A; Di Chiara G
    Psychopharmacology (Berl); 1989; 98(4):567-8. PubMed ID: 2570436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Eur J Pharmacol; 1988 Aug; 152(3):289-300. PubMed ID: 2906003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local cerebral glucose utilization after D1 receptor stimulation in 6-OHDA lesioned rats: effect of sensitization (priming) with a dopaminergic agonist.
    Morelli M; Pontieri FE; Linfante I; Orzi F; Di Chiara G
    Synapse; 1993 Mar; 13(3):264-9. PubMed ID: 8098880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of dopamine D-1 and D-2 receptor subtype agonists on nigrostriatal opioid dynorphin and enkephalin immunostaining in 6-hydroxydopamine lesioned rats.
    Jiang HK; Wang JY
    Chin J Physiol; 1991; 34(4):413-25. PubMed ID: 1687937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors.
    Braun AR; Chase TN
    Eur J Pharmacol; 1986 Nov; 131(2-3):301-6. PubMed ID: 3493161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of chronic exposure to selective D-1 and D-2 dopamine receptor agonists.
    Braun AR; Chase TN
    Eur J Pharmacol; 1988 Mar; 147(3):441-51. PubMed ID: 3259931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of dopamine D-1 and D-2 receptor agonists on EEG activity and behaviour in the rabbit.
    Ongini E; Caporali MG
    Neuropharmacology; 1987 Apr; 26(4):355-60. PubMed ID: 2953987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.